Author

Stefan Schreiber 1

1 1st Deparment Of Medicine, Universityhospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

A C-REL/NFTAC2/COX-2 PATHWAY CONFERS TRAIL RESISTANCE IN PANCREATIC CANCER

Claudia Geismann, Sebastian Zeissig, Philip Rosenstiel, Stefan Schreiber

A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF THE ORAL, GUT-RESTRICTED ALPHA4BETA7 INTEGRIN PEPTIDE ANTAGONIST PN-943 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE IDEAL STUDY

Scott Plevy, Bruce E. Sands, Julian Panés, Geert R. D'Haens, Vipul Jairath, Brian G. Feagan, Suneel Gupta, C. C. Hwang, Scott Lee, Alessandro Armuzzi, Walter Reinisch, Stefan Schreiber, William J. Sandborn

A prospective multi-center study on the prevalence of fructose malabsorption in patients withchronic inflammatory bowel disease

Ulf Helwig, Anna Katharina Koch, Kliniken Essen-Mitte,Essen,Germany, Christof Reichel, Petra Jessen, Betina Zietz, Jürgen Büning, Stefan Schreiber, Jost Langhorst

A ROLE FOR THE NADPH OXIDASES NOX1 AND P22PHOX IN VEOIBD

Simone Lipinski, Florian Tran, Britt Petersen, Stephanie Stengel, Matthias Barann, Marlene Jentzsch, Andre Franke, Stefan Schreiber, Philip Rosenstiel

A TREAT TO TARGET APPROACH DECREASES THE RATE OF CD-RELATED ADVERSE OUTCOMES VERSUS A CLINICAL APPROACH IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE: DATA FROM CALM

Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Filip Baert, T. Vanásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hebuterne, Simon Travis, Silvio Danese, Walter Reinisch, William Sandborn, Paul Rutgeerts, Daniel W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Zhou, Wan J Le

ACTIVE CROHN DISEASE IS ASSOCIATED WITH TRYPTOPHAN DEFICIENCY

Susanna Nikolaus, Natalie Massad, Johannes Bethge, Georg H Waetzig, Philip Rosenstiel, Ralf Junker, Florian Thieme, Stefan Schreiber

AN INTERPLAY BETWEEN AUTOPHAGY AND ER STRESS COORDINATES INTERLEUKIN-22 DEPENDENT SIGNALS IN THE INTESTINAL EPITHELIUM

Konrad Aden, Florian Tran, Maren Falk-Paulsen, Anne Luzius, Jan Kuiper, Robert Häsler, Raheleh Sheibani-Tezerji, Stefan Schreiber, Richard Steven Blumberg, Arthur Kaser, Philip Rosenstiel

ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR CROHN’S DISEASE: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY

Stefan Schreiber, Corey A Siegel, Keith Friedenberg, Ursula Seidler, Bal R. Bhandari, Ziad Younes, KE WANG, Matthew McKevitt, Sally Zhao, Bittoo Kanwar, John Sundy, Scott D. Lee, Edward V Loftus Jr

ANTI TNFA THERAPY MODULATES THE INTESTINAL MICROBIOTA ACROSS CHRONIC INFLAMMATORY DISEASE

Konrad Aden, ateequr rehmann, Wei-Hung Pang, Johannes Bethge, Susanna Nikolaus, rainald zeuner, Johann Oltmann Schroeder, Stefan Schreiber, Philip Rosenstiel

ANTI-TNF ALPHA THERAPY IN BIOLOGICS-NAϊVE ULCERATIVE COLITIS PATIENTS IN A PROSPECTIVE “REAL WORLD” STUDY IN GERMANY (BIOCOLITIS-REGISTRY)

Bernd Bokemeyer, Raja Atreya, Jürgen Büning, Tanja Kühbacher, Christian Maaser, Karen Schmidt, Petra Hartmann, Berit Wiebe, Stefan Schreiber

Item 1 - 10 / 150
1
2 3 4 5 6 7
...
14 15